Gritstone Bio Inc (GRTS)
0.7845
-0.19
(-19.36%)
USD |
NASDAQ |
May 10, 16:00
0.783
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Revenue (Quarterly): 0.029M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.029M |
| September 30, 2023 | 0.361M |
| June 30, 2023 | 0.40M |
| March 31, 2023 | 0.542M |
| December 31, 2022 | 1.327M |
| September 30, 2022 | 0.436M |
| June 30, 2022 | 2.761M |
| March 31, 2022 | 4.745M |
| December 31, 2021 | 1.78M |
| September 30, 2021 | 2.401M |
| June 30, 2021 | 2.843M |
| Date | Value |
|---|---|
| March 31, 2021 | 39.69M |
| December 31, 2020 | 0.918M |
| September 30, 2020 | 0.795M |
| June 30, 2020 | 0.488M |
| March 31, 2020 | 1.262M |
| December 31, 2019 | 0.884M |
| September 30, 2019 | 0.984M |
| June 30, 2019 | 1.15M |
| March 31, 2019 | 1.347M |
| December 31, 2018 | 1.091M |
| September 30, 2018 | 0.096M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.029M
Minimum
Dec 2023
39.69M
Maximum
Mar 2021
3.358M
Average
0.984M
Median
Sep 2019
Revenue (Quarterly) Benchmarks
| Precision BioSciences Inc | 7.038M |
| Humacyte Inc | -- |
| Verastem Inc | -- |
| BioVie Inc | -- |
| Adial Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.82M |
| Total Expenses (Quarterly) | 30.50M |
| EPS Diluted (Quarterly) | -0.26 |
| Enterprise Value | 37.80M |
| Profit Margin (Quarterly) | -106.3K% |
| Earnings Yield | -153.0% |
| Normalized Earnings Yield | -152.96 |